Class 1 innovative drug clinical trials growth rate

报告显示，2025年我国登记的2997项新药临床试验中，1类创新药有2171项，占比72.4%，同比增长4.1%；1类创新药临床试验抗肿瘤药物占比较高，占总体的37.5%。

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

National Healthcare Security Administration. (2025). 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Via StatOrigin, https://statorigin.org/stat/stat_XBDEETFHREBH7K3QRCNXDVAHPE

Copy

MLA

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025, http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_XBDEETFHREBH7K3QRCNXDVAHPE.

Copy

Chicago

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025. http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_XBDEETFHREBH7K3QRCNXDVAHPE.

Copy

BibTeX

@misc{nhsa2025classdvahpe, author = {{National Healthcare Security Administration}}, title = {国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_XBDEETFHREBH7K3QRCNXDVAHPE}, note = {Original source: http://www.nhsa.gov.cn/art/2026/6/23/art\_14\_21076.html. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_XBDEETFHREBH7K3QRCNXDVAHPE.